Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01239680 · ClinicalTrials.gov registry record · NA
Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy
A NA study, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01239680 is a NA study that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 5 participants.
The verdict
NCT01239680, a NA study, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Overall aim of this work is to evaluate new methods of resuscitation that can be applied by front-line responders on the battlefield, in civilian life, or which can be used during initial resuscitation in the first fixed facility to which the injured patient is brought.
Interventions
- DRUG Glutamine
- DRUG Ringer's Lactate
- DRUG Placebo (for Glutamine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01239680
The ClinicalTrials.gov registry entry for NCT01239680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri, Kansas City, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Glutamine is the first listed.
NCT01239680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01239680 about?
NCT01239680 is a clinical study titled "Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy". Overall aim of this work is to evaluate new methods of resuscitation that can be applied by front-line responders on the battlefield, in civilian life, or which can be used during initial resuscitation in the first fixed facility to which the injured patient is brought.
What is the current status of trial NCT01239680?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01239680?
The interventions under investigation include: Glutamine (DRUG), Ringer's Lactate (DRUG), Placebo (for Glutamine) (DRUG).
Who is sponsoring clinical trial NCT01239680?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.